Nearly 25 million U.S. women between the ages of 14 and 59 are infected with HPV, and the annual cost of screening and treating cervical abnormalities is about $4 billion, according to a statement from the Society of Gynecologic Oncologists.
A nationwide drug shortage is being felt here at home. Two main cancer drugs remain in short supply and some doctors are being forced to ration chemotherapy treatments.